Effects on Mood of Acute Phenylalanine/Tyrosine Depletion in Healthy Women

[1]  C. Benkelfat,et al.  Behavioral disinhibition induced by tryptophan depletion in nonalcoholic young men with multigenerational family histories of paternal alcoholism. , 1999, The American journal of psychiatry.

[2]  W. Riedel,et al.  Specificity of the tryptophan depletion method , 1999, Psychopharmacology.

[3]  C. McDougle,et al.  Tryptophan Depletion During Continuous CSF Sampling in Healthy Human Subjects , 1998, Neuropsychopharmacology.

[4]  R. Palmour,et al.  An amino acid mixture deficient in phenylalanine and tyrosine reduces cerebrospinal fluid catecholamine metabolites and alcohol consumption in vervet monkeys , 1998, Psychopharmacology.

[5]  P. Broderick.  Alprazolam, diazepam, yohimbine, clonidine: In vivo CA1, hippocampal norepinephrine and serotonin release profiles under chloral hydrate anesthesia , 1997, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[6]  M Diksic,et al.  Differences between males and females in rates of serotonin synthesis in human brain. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[7]  H L Miller,et al.  Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse. , 1997, Archives of general psychiatry.

[8]  F. Fadda,et al.  Acute administration of a tryptophan-free amino acid mixture decreases 5-HT release in rat hippocampus in vivo. , 1997, The American journal of physiology.

[9]  R. Roth,et al.  Mesoprefrontal dopaminergic neurons: can tyrosine availability influence their functions? , 1997, Biochemical pharmacology.

[10]  Peggy Dean,et al.  Mood Response to Acute Tryptophan Depletion in Healthy Volunteers: Sex Differences and Temporal Stability , 1996, Neuropsychopharmacology.

[11]  F. Artigas,et al.  Reduction of Serotonergic Function in Rat Brain by Tryptophan Depletion: Effects in Control and Fluvoxamine‐Treated Rats , 1996, Journal of neurochemistry.

[12]  G. Koob.  Hedonic valence, dopamine and motivation. , 1996, Molecular psychiatry.

[13]  E. Moja,et al.  Decrease in plasma phenylalanine and tyrosine after phenylalanine-tyrosine free amino acid solutions in man. , 1996, Life sciences.

[14]  P. Cowen,et al.  Use of a dietary manipulation to deplete plasma tyrosine and phenylalanine in healthy subjects , 1996, Journal of psychopharmacology.

[15]  N. Varney,et al.  Psychopharmacology: The Fourth Generation of Progress. , 1996 .

[16]  R. Wise,et al.  Addictive drugs and brain stimulation reward. , 1996, Annual review of neuroscience.

[17]  G. Belenky,et al.  The Effects of L-Dihydroxyphenylalanine on Alertness and Mood in α-Methyl-Para-Tyrosine-Treated Healthy Humans , 1995, Neuropsychopharmacology.

[18]  M. Fernstrom,et al.  Acute tyrosine depletion reduces tyrosine hydroxylation rate in rat central nervous system. , 1995, Life sciences.

[19]  Michael C. Neale,et al.  Stressful life events, genetic liability, and onset of an episode of major depression in women. , 1995, The American journal of psychiatry.

[20]  S A Shappell,et al.  The effects of tyrosine on cognitive performance during extended wakefulness. , 1995, Aviation, space, and environmental medicine.

[21]  C. Raftopoulos,et al.  Peripheral and central pharmacokinetics of apomorphine and its effect on dopamine metabolism in humans , 1995, Movement disorders : official journal of the Movement Disorder Society.

[22]  G. Belenky,et al.  The effects of L-dihydroxyphenylalanine on alertness and mood in alpha-methyl-para-tyrosine-treated healthy humans. Further evidence for the role of catecholamines in arousal and anxiety. , 1995, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[23]  J. Deijen,et al.  Effect of tyrosine on cognitive function and blood pressure under stress , 1994, Brain Research Bulletin.

[24]  C. Benkelfat,et al.  Mood-lowering effect of tryptophan depletion. Enhanced susceptibility in young men at genetic risk for major affective disorders. , 1994, Archives of general psychiatry.

[25]  C. Kirschbaum,et al.  The 'Trier Social Stress Test'--a tool for investigating psychobiological stress responses in a laboratory setting. , 1993, Neuropsychobiology.

[26]  Maria L. Thomas,et al.  Effects of Catecholamine Depletion on Alertness and Mood in Rested and Sleep Deprived Normal Volunteers , 1993, Neuropsychopharmacology.

[27]  M. Ansseau,et al.  Dopaminergic function in panic disorder: Comparison with major and minor depression , 1992, Biological Psychiatry.

[28]  Anthony G. Phillips,et al.  Dopamine functions in appetitive and defensive behaviours , 1992, Progress in Neurobiology.

[29]  O. Kah,et al.  Amino Acid Neurotransmitters and Dopamine in Brain and Pituitary of the Goldfish: Involvement in the Regulation of Gonadotropin Secretion , 1992, Journal of neurochemistry.

[30]  J. Uitto,et al.  EOSINOPHILIA‐MYALGIA SYNDROME , 1992, International journal of dermatology.

[31]  Larry J. Siever,et al.  Cortisol responses to mental arithmetic in acute and remitted depression , 1991, Biological Psychiatry.

[32]  P. Restani,et al.  Cycloheximide blocks the fall of plasma and tissue tryptophan levels after tryptophan-free amino acid mixtures. , 1991, Life sciences.

[33]  G. Belenky,et al.  Acute dystonic reaction in normal humans caused by catecholamine depletion. , 1990, Clinical neuropharmacology.

[34]  G. Baker,et al.  A rapid, sensitive assay for gamma-aminobutyric acid in brain using electron-capture gas chromatography. , 1990, Research communications in chemical pathology and pharmacology.

[35]  L. Cubeddu,et al.  Is the Release of Dopamine from Medial Prefrontal Cortex Modulated by Presynaptic Receptors? Comparison with Nigrostriatal and Mesolimbic Terminals , 1990, Annals of the New York Academy of Sciences.

[36]  F. Yocca.  Neurochemistry and Neurophysiology of Buspirone and Gepirone: Interactions at Presynaptic and Postsynaptic 5‐HT1A Receptors , 1990, Journal of clinical psychopharmacology.

[37]  G. Aghajanian,et al.  Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. , 1990, Archives of general psychiatry.

[38]  Harris R. Lieberman,et al.  Treatment with tyrosine, a neurotransmitter precursor, reduces environmental stress in humans , 1989, Brain Research Bulletin.

[39]  W. Iacono,et al.  Neurobehavioral aspects of affective disorders. , 1989, Annual review of psychology.

[40]  S. Lal.  Apomorphine in the evaluation of dopaminergic function in man , 1988, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[41]  R. Wurtman,et al.  Effects of systemic L-tyrosine on dopamine release from rat corpus striatum and nucleus accumbens. , 1988, Brain research.

[42]  J. Davis,et al.  Cerebrospinal fluid amine metabolites. Relationships with behavioral measurements in depressed, manic, and healthy control subjects. , 1986, Archives of general psychiatry.

[43]  J D Milner,et al.  Catecholamine synthesis: physiological coupling to precursor supply. , 1986, Biochemical pharmacology.

[44]  R. Roth,et al.  Regulation of dopamine synthesis in the medial prefrontal cortex: studies in brain slices. , 1986, The Journal of pharmacology and experimental therapeutics.

[45]  G. Gessa,et al.  Increase in stage 4 sleep after ingestion of a tryptophan-free diet in humans. , 1984, Pharmacological research communications.

[46]  D. Charney,et al.  Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder. , 1984, Archives of general psychiatry.

[47]  S. Tanganelli,et al.  Modulation of cortical acetylcholine and gamma-aminobutyric acid release in freely moving guinea pigs: effects of clonidine and other adrenergic drugs. , 1983, The Journal of pharmacology and experimental therapeutics.

[48]  M. Lorr,et al.  Evidence for bipolar mood states. , 1982, Journal of personality assessment.

[49]  C S Davidson,et al.  Diurnal variations in plasma concentrations of tryptophan, tryosine, and other neutral amino acids: effect of dietary protein intake. , 1979, The American journal of clinical nutrition.

[50]  G. Biggio,et al.  DECREASE OF HOMOVANILLIC, DIHYDROXYPHENYLACETIC ACID AND CYCLIC‐ADENOSINE‐3′,5′‐MONOPHOSPHATE CONTENT IN THE RAT CAUDATE NUCLEUS INDUCED BY THE ACUTE ADMINISTRATION OF AN AMINOACID MIXTURE LACKING TYROSINE AND PHENYLALANINE 1 , 1976, Journal of neurochemistry.

[51]  W H Oldendorf,et al.  Amino acid assignment to one of three blood-brain barrier amino acid carriers. , 1976, The American journal of physiology.

[52]  A. Bond,et al.  The use of analogue scales in rating subjective feelings , 1974 .

[53]  M. Lorr,et al.  Manual for the Profile of Mood States , 1971 .

[54]  A. Sjoerdsma,et al.  Biochemical and pharmacologic effects of α-methyltyrosine in man , 1968 .

[55]  W. Bunney,et al.  Norepinephrine in depressive reactions. A review. , 1965, Archives of general psychiatry.

[56]  A. Sjoerdsma,et al.  Inhibition of catecholamine synthesis in man with alpha-methyl-tyrosine, an inhibitor of tyrosine hydroxylase. , 1965, Lancet.

[57]  J. Schildkraut,et al.  The catecholamine hypothesis of affective disorders: a review of supporting evidence. , 1965, The American journal of psychiatry.

[58]  A. Beck,et al.  An inventory for measuring depression. , 1961, Archives of general psychiatry.